Back to Search
ROBERT WITHERSPOON, DMD
DMD
General Practice Dentistry
NPI: 1750578027Individual
Specialties, Licenses & Credentials
General Practice DentistryPrimary
Dentist — General Practice
Code: 1223G0001X
4189(KY)
Research & Publications (20)
Personalized dosing of cyclophosphamide in the total body irradiation-cyclophosphamide conditioning regimen: a phase II trial in patients with hematologic malignancy.
PMID 19295506·Clin Pharmacol Ther·2009
3-trial
Therapy with mycophenolate mofetil for refractory acute and chronic GVHD.
PMID 19377515·Bone Marrow Transplant·2009
3-trial
Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia.
PMID 17317589·Biol Blood Marrow Transplant·2007
4-observational
Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic disorders.
PMID 17488876·Blood·2007
8-other
Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen.
PMID 16635793·Biol Blood Marrow Transplant·2006
2-rct
Metabolism-based cyclophosphamide dosing for hematopoietic cell transplant.
PMID 16153400·Clin Pharmacol Ther·2005
8-other
A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation.
PMID 15983549·Biol Blood Marrow Transplant·2005
3-trial
Long-term acquisition of allergen-specific IgE and asthma following allogeneic bone marrow transplantation from allergic donors.
PMID 15280196·Blood·2004
8-other
Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantation.
PMID 14647254·Bone Marrow Transplant·2004
3-trial
Factors affecting antibody levels after allogeneic hematopoietic cell transplantation.
PMID 12506030·Blood·2003
3-trial
Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemoglobinuria.
PMID 14652852·Biol Blood Marrow Transplant·2003
5-case
Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation.
PMID 12942099·Bone Marrow Transplant·2003
8-other
Allogeneic hematopoietic stem cell transplantation for myelofibrosis.
PMID 12920019·Blood·2003
3-trial
The association between vitamin C and vitamin E supplement use before hematopoietic stem cell transplant and outcomes to two years.
PMID 12891146·J Am Diet Assoc·2003
8-other
Curative therapy of advanced essential thrombocythemia or polycythemia vera by hemopoietic stem cell transplantation.
PMID 12389621·Leuk Lymphoma·2002
8-other
Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome.
PMID 12149198·Blood·2002
3-trial
Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone.
PMID 12070007·Blood·2002
3-trial
Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease.
PMID 12014809·Biol Blood Marrow Transplant·2002
8-other
Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome after conditioning with busulfan and fractionated total body irradiation is associated with low relapse rate but considerable nonrelapse mortality.
PMID 11939606·Biol Blood Marrow Transplant·2002
3-trial
Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease.
PMID 11773890·Transplantation·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4100 HIDDEN FERN LN N
BARTLETT, TN 38135 - Phone
- (901) 734-1833
Quick Facts
- NPI
- 1750578027
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile